High sodium intake adversely affects oxidative-inflammatory response, cardiac remodelling and mortality after myocardial infarction  by Costa, Ana Paula R. et al.
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Objective:  Enhanced  sodium  intake  increases  volume  overload,  oxidative  stress  and  production  of  proin-
ﬂammatory  cytokines.  In animal  models,  increased  sodium  intake  favours  ventricular  dysfunction  after
myocardial  infarction  (MI).  The  aim  of this  study  was  to  investigate,  in  human  subjects  presenting  with
ST-segment  elevation  MI  (STEMI),  the  impact  of  sodium  intake  prior  the  coronary  event.
Methods: Consecutive  patients  (n =  372)  admitted  within  the  ﬁrst  24 h  of  STEMI  were  classiﬁed  by  a  food
intake  questionnaire  as  having  a chronic  daily  intake  of sodium  higher  (HS)  or lower  (LS)  than  1.2  g in  the
last  90  days  before  MI. Plasma  levels  of  8-isoprostane,  interleucin-2  (IL-2),  tumour  necrosis  factor  type 
(TNF-),  C-reactive  protein  (CRP)  and  brain  natriuretic  peptide  (BNP)  were  measured  at admission  and
at  the ﬁfth  day.  Magnetic  resonance  imaging  was  performed  immediately  after  discharge.  Total  mortality
and  recurrence  of  acute  coronary  events  were  investigated  over  4 years  of  follow-up.
Results: The  decrease  of  8-isoprostane  was  more  prominent  and  the  increase  of  IL-2,  TNF-  and  CRP  less
intense  during  the  ﬁrst  5 days  in  LS  than  in  HS  patients  (p  <  0.05).  Sodium  intake  correlated  with  change
in  plasma  BNP  between  admission  and  ﬁfth  day  (r =  0.46;  p  <  0.0001).  End-diastolic  volumes  of left  atrium
and  left  ventricle  were  greater  in  HS than  in  LS  patients  (p  <  0.05).  In the ﬁrst  30  days  after  MI  and  up to
4  years  afterwards,  total  mortality  was  higher  in HS  than  in  LS  patients  (p  <  0.05).
Conclusion:  Excessive  sodium  intake  increases  oxidative  stress,  inﬂammatory  response,  myocardial
stretching  and  dilatation,  and  short  and  long-term  mortality  after  STEMI.. Introduction
Although there is a large body of evidence and general consen-
us on the recommendation of moderate consumption of salt, there
re still conﬂicting results regarding the effect of salt intake on mor-
ality in the general population [1,2]. From the pathophysiological
oint of view, high salt intake may  increase the risk of cardiovas-
ular disease indirectly through the effect on blood pressure and
irectly by their structural and functional effects on the arterial
all, kidney and heart [3]. Hypothetically, at least part of the con-
roversy between the studies may  result from the wide variation
n the magnitude of the effect of sodium intake according to the
∗ Corresponding author. Tel.: +55 1935217098; fax: +55 1932894107.
E-mail  addresses: dclandrei@yahoo.com,  andreisposito@gmail.com
A.C.  Sposito).
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genetic background and comorbidities. In this context, advances in
understanding of the clinical effect of sodium intake may require
speciﬁcity in the population being studied [4].
Soon after the onset of myocardial infarction (MI) an anatomical
and functional remodelling is triggered through changes in both
the infarcted and remote areas in order to maintain stroke vol-
ume. Even though this remodelling process is driven to improve
cardiac function, it has been shown that in some conditions the
exacerbation of adaptative mechanisms may actually favour the
development of systolic and diastolic dysfunction and lead to an
increased risk of death [5].
In this phenotypic remodelling, inﬂammatory response is driven
to healing MI  lesions. Nevertheless, excessive inﬂammatory acti-
Open access under the Elsevier OA license.vation triggered by ischaemia, myocardial stretching or oxidative
stress may  favour the thinning and lengthening of the infarcted tis-
sue and eccentric hypertrophy and ﬁbrosis in remote areas [6,7]. In
parallel, myocardial wall stretching induced by pressure overload
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nd the generation of reactive oxygen species (ROS) by ischaemic
ells can also directly inﬂuence remodelling. These characteristics
ake the MI  patients potentially vulnerable to increased consump-
ion of sodium.
In a recent animal model study of MI,  a high salt intake was
ssociated with a more marked deterioration in contractile function
ollowing ischaemia–reperfusion injury [8].  In fact, besides the clas-
ic effect on pressure overload and ventricular stretching, a robust
et of evidence has demonstrated that excessive sodium intake can
irectly induce superoxide generation [9],  and proinﬂammatory
ytokines secretion [10]. By inference, it is plausible that a high
alt intake may  adversely inﬂuence cardiac remodelling and con-
equently deteriorates the clinical outcome after MI.  To verify this
ypothesis in humans, we investigated the inﬂuence of the magni-
ude of chronic sodium intake on inﬂammatory-oxidative response,
ardiac remodelling and total mortality after MI.
. Methods
.1. Patients
Study subjects (n = 372) were participants in the ongoing Brasilia
eart Study (BHS) [11]. Brieﬂy, in this prospective cohort, consec-
tive patients who spontaneously sought medical care and were
iagnosed ST-segment elevation MI  at the emergency department
f the Hospital de Base do Distrito Federal in Brasilia were included
n the study as of May  2006. For this analysis, we included all
onsecutive patients enrolled into the study until October 2010.
nclusion criteria are as follows: (i) less than 24 h after the onset of
I symptoms, (ii) ST-segment elevation of a least 1 mm  (frontal
lane) or 2 mm  (horizontal plane) in two contiguous leads, and
iii) myocardial necrosis, as evidenced by increased creatine kinase
soenzyme MB  (CK-MB) and troponin I levels. We  excluded patients
ho were mentally incapable of answering the questionnaires, or
ad neoplastic disease, chronic renal failure on dialysis, severe liver
isease, heart failure (based on clinical and radiological evaluation)
r who manifested MI  during a hospitalisation.
The ﬁrst blood sample was drawn at admission followed by
omplete medical and nutritional evaluations within 24 h of MI
ymptoms onset. A standardised questionnaire was conducted to
nvestigate nutritional, medical history, medications in use and
ifestyle. Hypertension was deﬁned as a repeatedly elevated blood
ressure exceeding 140 over 90 mmHg  during hospitalisation or
egular treatment for hypertension prior to MI.  Sedentary lifestyle
as deﬁned as <30 min/day of sports activities. Smoking was
eﬁned as the use of one or more cigarettes per day for more than
 year before the MI.
The second blood sample was drawn at the ﬁfth day of hospi-
alisation. All medical treatment was conducted by the attending
hysicians without interference of the study investigators. The
tudy was approved by the Institutional Ethics Committee, and all
atients signed an informed consent.
.2. Assessment of sodium intake
Urinary sodium excretion during 24 h has been frequently used
o estimate daily sodium intake. In patients with MI,  however, a
arge number of variables, including secretion of natriuretic pep-
ides and use of diuretics, preclude the interpretation of this assay.
n this context, we selected to estimate the dietary intake of sodium
sing the food frequency questionnaire. The questionnaire assessed
ietary intake over the last 90 days of 62 food items divided into
0 groups (milk products, eggs and meat, oils, snacks and canned
oods, cereals and legumes, vegetables and fruits, desserts and
weets, beverages, diet and light products and spices). The foodsis 222 (2012) 284– 291 285
portions in household measures were standardised with the help
of a photographic record for dietary inquiries and the portion sizes
were transformed into weights. Dietary intake of sodium was  quan-
tiﬁed according to food composition of the Brazilian Table of Food
Composition – version 2 [12]. The quantiﬁcation of sodium intake
from the questionnaires was performed by an experienced nutri-
tionist (A.P.R.C.) and the values were omitted from all other study
participants.
2.3. Questionnaire validation
In order to validate the quantiﬁcation of the daily intake of
sodium by the study’s questionnaire, 21 volunteers were enrolled
(9 men, 49 ± 9 years old). Exclusion criteria were use of diuret-
ics, diabetes, hypertension, renal disease (creatinine clearance
<60 mL/min/1.73 m or proteinuria) and obesity (BMI >30 kg/m2).
The decision on selecting volunteers for the validation was  based
on the decoupling between sodium intake and excretion during
the acute phase of MI  secondary to neurohumoral activation and
use of loop diuretics. In two  non-consecutive days within a range
not exceeding 5 days, 24 h’s urine was  collected for quantiﬁcation
of urinary sodium excretion. In the following week after sodium
excretion measurement the food questionnaire was applied in two
separate occasions by the two  experienced nutritionists who par-
ticipated in this study. These data were used to evaluate intra
and interobserver variability and to compare these two meth-
ods.
2.4. Cardiac magnetic resonance imaging (CMRI)
CMRI studies were performed 2 weeks after hospital discharge
with a 1.5-T MRI  scanner (Signa CV/i, GE Medical Systems, Wauke-
sha, WI)  equipped with high-performance gradients (gradient
strength 40 mT/m;  maximum slew rate 150 mT/m/s) and a four
elements phased array cardiac coil. Myocardial infarction areas
were quantiﬁed on the gadolinium-based delayed enhancement
myocardial images. On cine-CMRI end-systolic and end-diastolic
left atrium (LA) and left ventricle (LV) volumes and ejection frac-
tion were measured by ReportCard software (GE Medical Systems,
Waukesha, WI), applying Simpson’s method.
2.5. Laboratory analyses
Glycosylated haemoglobin (HbA1c) (Variant II, Bio-Rad Labo-
ratories, Hercules, CA, USA) was measured at admission and the
following blood measurements were performed at admission and
at the ﬁfth day: glucose (Glucose GOD-PAP, Roche Diagnostics,
Mannheim, Germany), 8-isoprostane (EIA kit, Cayman Chemical
Company, Ann Arbor, MI,  USA), CRP (high-sensitivity CRP, Car-
diophase, Dade Behring, Marburg, Germany), interleucin-2 (IL-2)
(Fluorokine® MAP  Human IL-2 Kit, R&D Systems, Minneapolis,
MN, USA) tumour necrosis factor type  (TNF-)  (Fluorokine®
MAP  Human TNF- Kit, R&D Systems, Minneapolis, MN,  USA)
and B-type natriuretic peptide (BNP) (BNP-32, Human EIA kit,
Phoenix Pharmaceuticals Ca, USA), total cholesterol (CHOD-PAP,
Roche Diagnostics, Mannheim, Germany), triglycerides (GPO-PAP,
Roche Diagnostics, Mannheim, Germany), HDL cholesterol (HDL
cholesterol without sample pre-treatment, Roche Diagnostics,
Mannheim, Germany). LDL cholesterol was calculated by the
Friedewald formula.2.6. Medical treatment during follow-up phase
After hospital discharge, patients were referred to a guideline-
driven medical therapy at the BHS outpatient clinic. Lifestyle
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Fig. 1. Consistency between sodium intake estimated by the questionnaire and 24-h sodium excretion. Linear regression curve and Pearson’s correlation analysis (A) and
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1land–Altman difference plot (B) between sodium intake estimated by the question
ounselling for diet, smoking cessation, regular physical activ-
ty and weight loss was offered to all patients. The follow-up
rescriptions included statin (LDL-C goal of 70 mg/dL), capto-
ril or losartan for hypertension or reduced ejection fraction
<40%); metformin and glybenclamide for glyceamic control;
spirin 100 mg/day; clopidogrel 75 mg/day for the ﬁrst 30 days
fter MI;  and anti-ischaemic therapy as required (propranolol and
sosorbide dinitrate, alone or in combination).
.7. Clinical outcome
The outcomes were recorded from 48 h after the onset of MI  to
void bias related to early deaths secondary to arrhythmias in the
cute phase, concomitant chronic diseases or the extent and sever-
ty of MI.  The primary outcome was total mortality in the ﬁrst 30
ays after MI.  Secondary outcomes were: (i) total mortality during
he entire follow-up; and (ii) composite endpoint of fatal or non-
atal MI  and unstable angina requiring hospitalisation, from now
n deﬁned as major coronary events (MACE).
.8. Statistical methods
Data are presented as mean ± standard deviation for normally
istributed data or median (interquartile range) for skewed data.
ategorical variables were compared by using the chi-square test.
nalysis of covariance (ANCOVA) was employed to assess the asso-
iation between sodium intake and change of plasma levels of IL-2,
NF-, and CRP between the ﬁrst and ﬁfth day after MI. Adjust-
ent for baseline levels, age and gender were performed in all
omparisons. Assumptions of the ANCOVA models (linearity, nor-
ality of distribution and equal variance) were checked using
istograms, normal probability plots and residual scatter plots. Log-
rithmic transformation was applied to the variables 8-isoprostane,
L-2, TNF-, CRP and glomerular ﬁltration rate to correct skew-
ess before performing ANCOVA analyses. Follow-up duration was
ensored at the time of the last contact. Estimates of the cumu-
ative event rate were calculated by the Kaplan–Meier method
nd the comparison between curves was made by log rank test.
ox regression method was used for detecting variables indepen-
ently associated with time to cardiovascular event. A two-sided
-value of 0.05 was considered statistically signiﬁcant. Statisti-
al analyses were performed using PASW for Windows version
8.0. and 24-h sodium excretion.
3. Results
3.1. Questionnaire validation
There was  a variation of 0.3 ± 1.4 g or 11 ± 36% between the
two  measures of 24-h urinary excretion of sodium. The intra and
interobserver variability for the food frequence questionnaire was
veriﬁed for sodium intake (1 ± 3% and 3 ± 10%, respectively) and
for total daily calorie intake (0 ± 3% and 3 ± 8%, respectively). The
averages of two measurements of sodium excretion and of two  esti-
mations of sodium intake were used for the comparison between
the methods. As shown in Fig. 1A, a strong signiﬁcant correlation
was  observed between 24-h urinary excretion of sodium and the
questionnaire-based estimation of sodium daily intake (r = 0.84;
p < 0.0001). The Bland–Altman analysis (Fig. 1B) indicates that the
95% limits of agreement between the two methods ranged from
0.5 to 2.5. In fact, the absolute value of the 24-h urinary excretion
of sodium was consistently 1.5 ± 0.5 g greater than the estimated
daily intake of sodium by the questionnaire.
3.2. Patients’ characteristics
The study population was divided into two groups according to
median value of daily sodium intake ≥1.2 g/day (HS) or <1.2 g/day
(LS). As shown in Table 1, the mean age in HS group was  lower
than in the LS group. There was  no other signiﬁcant difference in
the admission characteristics between the groups. Equally, there
was  no difference between groups neither in the therapy adminis-
tered during hospitalisation nor in the elapsed time between the MI
symptoms onset and hospital admission (Table 1). Patients treated
by primary angioplasty only received bare metal stents.
Baseline blood pressure and its change during hospitalisation
were not different between the groups. Also, the treatment with
blood pressure lowering drugs or furosemide was similar in both
groups (Table 1). Nevertheless, pulmonary congestion, as semi-
quantiﬁed by Killip score, was more frequent and more severe in HS
group as compared with LS (Table 3). There was  no signiﬁcant asso-
ciation between sodium intake and alcohol intake, smoking habit,
family income or education level estimated by years of study. There
was, however, a signiﬁcant correlation between sodium intake and
percentage of fat on daily total calorie intake (r = 0.3; p = 0.001).
There was  no difference in family income (US$ 1251 ± 680 versus
1102 ± 693; p = 0.5) or education (6.8 ± 5.0 versus 6.5 ± 4.6 years;
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Table 1
Characteristics of studied patients at admission.
≥1.2 g/day <1.2 g/day p
n 218 154
Daily sodium intake, g 2.6 ± 0.8 0.8 ± 0.2
Sodium/calorie ratio, mg/kcal 0.8 ± 0.3 0.4 ± 0.1 0.0001
Age,  years 57 ± 10 61 ± 11 0.002
Male,  % 76 71 0.300
Body  mass index, kg/m2 27 ± 5 27 ± 4 0.327
Waist circumference, cm 97 ± 12 96 ± 14 0.464
Prior  MI,  % 11 8 0.600
Diabetes Mellitus, % 20 19 1.000
Metabolic syndrome, % 49 43 0.567
HbA1c, % 6.4 ± 1.3 6.7 ± 2.1 0.335
Blood glucose, mg/dL 137 ± 53 146 ± 85 0.249
Smoking habit, % 39 36 0.700
Sedentary, % 58 50 0.200
Hypertension, % 54 65 0.070
Systolic blood pressure, mm Hg 136 ± 33 135 ± 31 0.831
Diastolic blood pressure, mm Hg 87 ± 21 84 ± 19 0.194
Heart rate, bpm 76 ± 18 76 ± 16 0.871
Glomerular ﬁltration rate, mL/min/1.73 m2 70 (59–84) 70 (55–82) 0.36
LDL  cholesterol, mg/dL 124 ± 45 117 ± 42 0.133
HDL  cholesterol, mg/dL 39 ± 12 39 ± 10 0.643
Triglycerides, mg/dL 167 ± 117 149 ± 124 0.197
Time  from MI onset to admission, min  203 ± 276 179 ± 231 0.8
Primary angioplasty, % 17 19 0.6
Tenecteplase, % 64 59 0.4
Statins, % 69 66 0.6
Betablockers, % 66 63 0.7
Losartan, % 2.7 2.3 1.0
Captopril, % 56 53 0.6
Furosemide, % 11 7 0.4
Aspirin, % 95 97 0.2
Clopidogrel, % 55 58 0.7
Non-fractioned heparin, % 38 38 1.0
M prote
p
1
3

T
P
IEnoxaparin, % 50 
I:  myocardial infarction; HbA1c: glycosylated haemoglobin, LDL: low-density lipo
 = 0.9) among patients with sodium intake greater or less than
.2 g/day..3. Oxidative stress and inﬂammatory response
As shown in Table 2, plasma levels of 8-isoprostane, IL-2, TNF-
 and CRP were similar in both groups on admission. In both
able 2
lasma biomarkers during MI  according to the mean sodium intake before the coronary e
≥1.2 g/day 
8-Isoprostane, pg/mL
Admission 36 (25–51) 
Fifth  day 31 (23–43) 
Variation 1 (−10 to +12) 
IL-2,  pg/mL
Admission 0.8 (0.3–1.9) 
Fifth  day 6.0 (4.1–11.2) 
Variation 5.0 (2.4–9.8) 
TNF-,  pg/mL
Admission 5.0 (0.6–11.9) 
Fifth  day 15.3 (6.6–35.2) 
Variation 7.9 (2.3–27.5) 
CRP,  mg/L
Admission 0.6 (0.3–1.3) 
Fifth  day 4.1 (2.1–10.2) 
Variation 2.8 (1.3–7.5) 
BNP,  ng/mL
Admission 0.2 ± 0.2 
Fifth  day 0.9 ± 1.4 
Variation, % 152 ± 156 
Peak  of CK-MB, /L 244 ± 273 
Peak  of troponin I, ng/dL 70 ± 77 
L-2: interleucin-2; TNF-: tumour necrosis factor type ; CRP: C-reactive protein; BNP: 51 0.9
in; HDL: high-density lipoprotein.
groups the levels of 8-isoprostane decreased during the ﬁrst 5
days, but the reduction was more prominent in LS group than in
HS. The systemic inﬂammatory activity, as estimated by IL-2, TNF-
 and CRP, increased from baseline to the ﬁfth day, but the rise
was  more intense in HS group as compared with LS group. Direct
correlations were found between sodium intake and delta TNF-
(r = 0.29; p = 0.001) and delta 8-isoprostane (r = 0.2; p = 0.006). These
vent.
<1.2 g/day p
37 (26–54) 0.39
21 (16–29) 0.01
−10 (−33 to 0) 0.004
0.9 (0.4–2.2) 0.457
5.2 (3.8–9.2) 0.02
4.3 (1.8–7.0) 0.012
5.3 (0.2–12.2) 0.66
6.5 (1.5–24.6) 0.02
2.7 (−0.1 to 9.2) 0.002
0.5 (0.3–1.4) 0.2
3.2 (1.5–6.5) 0.03
2.0 (0.9–4.9) 0.063
0.2 ± 0.1 0.19
0.3 ± 0.2 0.01
59 ± 115 0.001
259 ± 237 0.63
73 ± 67 0.59
B-type natriuretic peptide; CK-MB: creatine kinase isoenzyme MB.
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Table 3
Killip score and CMRI data.
≥1.2 g/day <1.2 g/day p
Killip score 0.02
Class  I, % 84 94
Class II, % 9 4
Class  III, % 5 0
Class  IV, % 2 2
MI  mass, g 17 ± 12 16 ± 8 0.19
End-diastolic volume of the LV, mL  150 ± 51 134 ± 35 0.02
Ejection fraction of the LV, % 42 ± 18 46 ± 13 0.21
End-diastolic volume of the LA, mL 73  ± 23 60 ± 22 0.01
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LEjection fraction of the LA, % 33 ± 15 
I:  myocardial infarction; CMRI: cardiac magnetic resonance imaging; LV: left ven
orrelations remained signiﬁcant after adjustment for gender and
ge. The association between sodium intake and delta CRP (p = 0.08)
nd delta IL-2 (p = 0.052) did not reach statistical signiﬁcance.
.4. Myocardial wall stretching
During the ﬁrst 5 days after MI  onset, plasma levels of BNP
ncreased signiﬁcantly in all enrolled patients (p < 0.05). The rise
f plasma BNP was more pronounced among patients from the HS
roup than in those from the LS group (Table 2). In fact, a signiﬁ-
ant correlation was found between the amount of daily intake of
odium and change in plasma BNP from admission to the ﬁfth day
r = 0.46, p < 0.0001). Consistently, there was a weak but signiﬁcant
orrelation between the amount of the daily intake of sodium and
he LV end diastolic volume (r = 0.37; p = 0.027). This correlation
emained signiﬁcant after adjustment for age and gender (0.41;
 = 0.011)
.5. Short-term cardiac remodelling
As commented above, CMRI was performed 2 weeks after hos-
ital discharge, which represented around 3 weeks after the onset
f MI  symptoms. There was no difference between the two groups
n the MI  mass as estimated either by CK-MB peak or CMRI with
elayed enhancement (Table 3). In analyses adjusted for gender,
ge, mass of MI,  and body surface area (BSA), the mean end-diastolic
olume of the LV and LA were signiﬁcantly higher in HS than in
S group (Table 3). The ejection fraction of LV and LA tended to
able 4
ultivariable analyses by the Cox test.
Wald p 
Model 1
Age 24.012 0.000 
Gender 0.001 0.971 
High  sodium intake 17.689 0.000 
Model 2
Age 24.480 0.000 
Gender 0.624 0.430 
Hypertension 0.522 0.470 
BMI  1.502 0.220 
Diabetes 1.831 0.176 
Sedentarity 0.766 0.381 
High  sodium intake 10.224 0.01 
Model 3
Age 10.844 0.001 
Gender 0.658 0.417 
MI  mass 0.096 0.757 
LVDV  20.164 0.000 
CRP  on the ﬁfth day 2.379 0.036 
BNP  on the ﬁfth day 3.959 0.047 
High  sodium intake 5.519 0.019 
VDV: left ventricle end-diastolic volume; CRP: C-reactive protein; BNP: B-type natriuret37 ± 13 0.23
 LA: left atrium.
be lower in HS than in LS group, but the difference did not reach
statistical signiﬁcance.
3.6. Clinical outcome
During the entire follow-up period (370 ± 189 days) there were
20 MI,  29 unstable angina requiring hospitalisation, 61 fatal MI
or sudden deaths, deﬁned as non traumatic death occurring sud-
denly or unexpectedly <24 h after the onset of the symptoms, and
5 non-cardiovascular deaths (1 suicide, 1 neoplasm, 3 infection).
In the ﬁrst 30 days after MI,  total mortality was  higher in HS
than in LS (Fig. 2A). Considering the total follow-up period, the
difference in survival in favour of the LS group remained signiﬁ-
cant (Fig. 2B). This difference remained signiﬁcant after excluding
the non-cardiovascular deaths (p = 0.02). However, 86% of deaths
occurred within the ﬁrst 30 days after admission. The incidence of
MACE did not differ between groups during the ﬁrst 30 days as well
as for the entire follow-up period (Fig. 2C). In a survival analysis
including only patients with LV ejection fraction >40% at discharge
(n = 319), high sodium intake remained signiﬁcantly associated
with increase in mortality (log rank p = 0.042). The event-free sur-
vival was equally different when we  separated the patients in
groups with sodium/calorie ratio higher or lower than the median
value of 0.6 mg/kcal (log rank p = 0.001).As shown in Table 4, in this ﬁrst Cox modelling age, gen-
der, and sodium intake >1.2 g/day were included. The risk of
death was  3.6 times higher among individuals with high sodium
intake. In a second modelling, diagnoses of hypertension, diabetes,
Exp(B) 95.0% CI for Exp(B)
Lower Upper
1.060 1.035 1.085
1.010 0.588 1.735
3.620 1.988 6.592
1.073 1.044 1.104
0.762 0.388 1.497
1.239 0.693 2.215
1.038 0.978 1.101
1.803 0.768 4.234
0.777 0.442 1.367
2.857 1.501 5.437
1.058 1.023 1.094
0.705 0.303 1.641
0.990 0.929 1.055
1.121 1.066 1.178
1.121 1.056 1.634
1.311 1.004 1.711
2.768 1.184 6.473
ic peptide; BMI: body mass index.
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Fig. 2. Actuarial curves at short and long term after MI  according to salt intake.
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oronary events during the entire follow-up (C).
edentarity and body mass index (BMI) were included and the
egree of association between high salt intake and mortality was
ttenuated but remained signiﬁcant. In a third model, MI  mass and
V end-diastolic volume both quantiﬁed by CMRI, and plasma levels
f CRP and BNP measured on the ﬁfth day after MI  were included
n the modelling. As the second model, the combination of high
odium intake with mortality was attenuated but remained signif-
cant. Besides enhanced sodium intake, LV end-diastolic volume,
RP and BNP were also independently associated with risk of death
Table 4).sis 222 (2012) 284– 291 289
Delta IL-2 and TNF- were not included due to the high
collinearity with delta CRP. Nevertheless, the substitution of the
delta CRP for delta IL-2 or TNF- did not change the result. The
exchange of the variables LV end-diastolic volume and LV ejection
fraction did not change the degree of association between high salt
intake, CRP or BNP and total mortality. With this exchange, LV ejec-
tion fraction was  signiﬁcantly associated with risk of death (Exp(B)
0.82 95% conﬁdence interval 0.69–0.97).
4. Discussion
A robust body of evidence has indicated that excessive sodium
intake increases myocardial stretch [13], production of ROS [9]
and of proinﬂammatory cytokines [10], and in animal models, it
increases the deterioration in LV contractile function following MI
[8]. Hence, the present study was designed to verify whether in
patients who  are especially vulnerable to this set of actions, i.e.
those in the acute phase of STEMI, a prior history of excessive
sodium intake can adversely affect their biological adaptation and
clinical outcome after MI.  The present investigation revealed that
individuals who have a chronic increase of sodium intake prior to
MI  manifest: (i) increased oxidative stress and systemic inﬂam-
matory response, (ii) increased production of BNP, (iii) increased
end-diastolic volume of LV and LA shortly after MI,  and, most
importantly, (iv) present an increase by about 3.6 times of the risk
of death.
After ischaemia–reperfusion tissue damage during MI,  ROS par-
ticipates in the activation of local inﬂammatory response, which
is vital for tissue repair. However, a higher generation of ROS
can deteriorate ventricular remodelling via a spectrum of mech-
anisms (see ref. [14] for more details). ROS activates intracellular
signalling pathways such as mitogen-activated protein kinases
(MAPKs), small GTP-binding proteins and the Src family of tyro-
sine kinases and thus induces cellular hypertrophy and apoptosis
[15]. Consistently, reduced NAD(P)H oxidase activity decreases
cardiomyocytes apoptosis in the infarcted area and attenuates
hypertrophy and ﬁbrosis in the non-infarcted myocardium [16,17].
Therefore, a ﬁne balance in the production of ROS is required to
restrict myocardial injury and ventricular remodelling.
It has been shown that enhanced sodium intake directly stimu-
lates ROS generation via upregulation of NADPH and NADH oxidase
activities [18]. In agreement with that, study participants who had
high intakes of sodium prior to MI  manifested a persistent ele-
vation of oxidative stress, as estimated by plasma 8-isoprostane
levels, during the ﬁrst 5 days after the onset of MI.  Participants who
reported a lower daily sodium intake had a progressive decrease in
oxidative stress during this period.
As noted above, by itself, the persistent increase in oxidative
stress can negatively inﬂuence cardiac remodelling. In addition,
ROS can also activate nuclear factor B mediated through signal-
regulating kinase 1 and by this way stimulates inﬂammatory
response. Thus, high sodium intake can stimulate the inﬂammatory
response by various mechanisms including increase of oxidative
stress, reduction of NO bioavailability, and direct activation of
MAPK-p38 [9,10].  In patients with STEMI, we observed that high
sodium intake is associated with a greater increase in IL-2, TNF-
 and CRP as compared with that observed in individuals in the
LS group. Such imbalance in favour of the pro-inﬂammatory state
may  facilitate the extension and expansion of MI,  exacerbate car-
diac remodelling and increase mortality in the short and medium
terms [19].Myocardial wall stretch triggers MAPKs that rapidly stimulate
transcription of transforming growth factor -1, collagen types I
and III, -myosin heavy chain, -skeletal actin, which may lead
to cell hypertrophy and ﬁbrosis in remote regions from the MI
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order [20,21]. As part of this cascade of secondary messengers, the
tretch of the myocardium strongly induces the secretion of BNP in
he blood, and its magnitude is directly related to risk of cardio-
ascular death and heart failure after MI.  Consistent with previous
tudies in patients with STEMI, we found elevated BNP values [22].
owever, we observed that plasma levels of this peptide rise three
imes more in the ﬁrst 5 days after MI  in patients with enhanced
alt intake and that they remain at a similar level in patients with
ow salt intake. This difference was observed although both groups
ad similar blood pressure at admission, raising questions about
he possibility of effects of sodium independent of pressure over-
oad. New studies, however, using continuous assessment of blood
ressure during the acute phase of MI  are required to substantiate
his hypothesis.
Sodium intake was not associated with MI  mass, but it was  pos-
tively associated with increased LV and LA end-diastolic volume
easured about 3 weeks after MI.  In line with previous studies
23,24], both LV diastolic diameter and BNP were signiﬁcantly and
ndependently associated with the risk of death after MI.  After the
ddition of BNP and CRP measured on the ﬁfth day after MI,  and
I mass and LV end-diastolic volume estimated by CMRI to Cox
odelling, the risk of death related to chronic intake of sodium
as reduced from 3.6 to 2.7 but remained statistically signiﬁcant.
his ﬁnding suggests that these variables are part of the mecha-
isms by which high sodium intake increases mortality, but it also
uggests the existence of additional mechanisms not known or not
easured in this study.
Conﬂicting results have been found in the investigation of
he association between sodium intake and acute coronary risk
4,25,26]. Among the possibilities for this divergence are the wide
ariation in the methodology for measuring daily intake of sodium,
he differences between the studied populations or in the extension
f the follow-up period. The present study was not powered for
esting the small difference we found in MACE incidence between
he groups. Further studies are necessary to clarify this issue.
The accurate measurement of daily sodium balance remains
 challenge in clinical research. Dietary recall questionnaire and
rinary excretion of sodium in 24 h have been used due to its con-
enience and reproducibility. However, daily variability of sodium
ntake may  cause an observation window of 24 h to under- or
verestimate the actual consumption. In addition, sodium daily
xcretion may  be inﬂuenced by medical conditions or drugs that
romote natriuresis. In this context, in patients with MI, sodium
ntake is restricted and natriuresis stimulated by neurohumoral
ctivation and use of natriuretic drugs. In some studies, this lim-
tation has been mitigated with sequential sampling. However, in
atients with acute MI,  this approach is not feasible. In order to
itigate these limitations, we used a detailed questionnaire recall
62 items) taking into account food intake in the last 90 days before
I.
The questionnaire was compared to two consecutive mea-
ures of urinary sodium excretion in 24 h in 21 healthy subjects.
espite the consistency between the methods indicated by the
trong correlation magnitude, we found that urinary excretion was
pproximately 1.5 g higher, thus suggesting a systematic underes-
imation by the questionnaire. Considering that the questionnaires
ere conducted with the utmost care, as indicated by the low intra
nd interobserver variability, this ﬁnding may  be due to limitations
uch as the possibility of recall bias and by natural variation in the
omposition of natural products due to weather, soil, cultivation
echniques, etc. Thus, even though this study was able to separate
wo populations with distinct sodium consumption the limitations
n the dietary questionnaire may  have led us to underestimate the
ctual daily sodium intake. Hence, although the exact amount of
odium that could induce the observed effects is imprecise, the
xistence of these associations is not.
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In conclusion, the progressive increase in salt intake observed
worldwide has generated apprehension. The present ﬁndings rein-
force this concern and indicate that individuals with an increased
sodium intake present after MI  a higher oxidative stress, inﬂamma-
tory response, myocardial stretching and remodelling, and, most
importantly, higher total mortality. This information must be con-
sidered especially in the care of individuals at high risk of acute
coronary events.
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